KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Change in Inventory (2016 - 2026)

AbbVie has reported Change in Inventory over the past 14 years, most recently at $25.0 million for Q4 2025.

  • Quarterly Change in Inventory fell 80.47% to $25.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $234.0 million through Dec 2025, down 26.65% year-over-year, with the annual reading at $234.0 million for FY2025, 26.65% down from the prior year.
  • Change in Inventory was $25.0 million for Q4 2025 at AbbVie, up from -$2.0 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $385.0 million in Q1 2022 and troughed at -$219.0 million in Q3 2021.
  • The 5-year median for Change in Inventory is $69.5 million (2024), against an average of $89.9 million.
  • Year-over-year, Change in Inventory crashed 156.47% in 2023 and then surged 233.33% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $112.0 million in 2021, then surged by 51.79% to $170.0 million in 2022, then crashed by 156.47% to -$96.0 million in 2023, then surged by 233.33% to $128.0 million in 2024, then plummeted by 80.47% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Change in Inventory are $25.0 million (Q4 2025), -$2.0 million (Q3 2025), and $56.0 million (Q2 2025).